You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TVTX Sale Disclosure
Lyons Gary A · SEC Form 4 · Filed Aug 19, 2026
Sale
Calculated transaction value
$57.47K
Lyons Gary A Director
TVTX
Travere Therapeutics
TVTX
Transaction date
Aug 18, 2026
Public filing date
Aug 19, 2026
Filing lag
Filed 1 day later
TVTX daily price context
Close on/before transaction
$63.9
Aug 18, 2026
First close after public filing
$64.46
Aug 20, 2026
30-day return after filing
-2.64%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 900 shares @ $63.86
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001123343-26-000010
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$807.25K
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Travere Therapeutics, Inc. TVTX | Sale | Aug 18, 2026 | $259.39K |
| Travere Therapeutics, Inc. TVTX Current | Sale | Aug 18, 2026 | $57.47K |
| Travere Therapeutics, Inc. TVTX | Exercise | Aug 18, 2026 | $87.2K |
| Travere Therapeutics, Inc. TVTX | Exercise | Aug 18, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Sale | Aug 17, 2026 | $165.1K |
| Travere Therapeutics, Inc. TVTX | Sale | Aug 17, 2026 | $32.08K |
| Travere Therapeutics, Inc. TVTX | Exercise | Aug 17, 2026 | $0 |
| Travere Therapeutics, Inc. TVTX | Exercise | Aug 17, 2026 | $87.2K |
| Travere Therapeutics, Inc. TVTX | Sale | Aug 17, 2026 | $118.8K |